TG101348
| CAS No. | 936091-26-8 | Cat. No. | BCP02300 |
| Name | TG101348 | ||
| Synonyms | TG-101348;TG 101348;Fedratinib;SAR302503;SAR-302503;SAR 302503; | ||
| Formula | C27H36N6O3S | M. Wt | 524.68 |
| Description | Fedratinib is an oral selective inhibitor of Janus associated kinase 2 (JAK-2) and FMS-like tyrosine kinase 3 (FLT3) that is used in the therapy of intermediate or high-risk, primary or secondary myelofibrosis. | ||
| Pathways | Angiogenesis/Protein Tyrosine Kinase Jak/Stat Pathway Wnt/Stem Cell Epigenetics | ||
| Targets | Epigenetic Reader Domain JAK | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.